Maud Maillard
Maud Maillard publishes mostly in Oncology, Public Health, Environmental and Occupational Health and Molecular Biology, on topics such as Acute Lymphoblastic Leukemia research, Colorectal Cancer Treatments and Studies and Chemotherapy-induced organ toxicity mitigation.
- World rank
- #2,870,022 of 7,710,434 ranked researchers
- Rank in France
- #121,846 of 324,115
- Works
- 27
- Citations
- 160
- Citations per work
- 5.9
What does Maud Maillard research?
Maud Maillard's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (9%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1245.5%
- Medicine1245.5%
- Everything else1139.3%
- Life Sciences415.2%
- 1Oncology20% of their works
- 2Public Health, Environmental and Occupational Health12% of their works
- 3Molecular Biology9% of their works
- 4Pathology and Forensic Medicine8% of their works
- 5Pediatrics, Perinatology and Child Health6% of their works
- 6Pharmacology6% of their works
Research topics
- Acute Lymphoblastic Leukemia research
- Colorectal Cancer Treatments and Studies
- Chemotherapy-induced organ toxicity mitigation
- Blood disorders and treatments
- Biochemical and Molecular Research
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Chronic Lymphocytic Leukemia Research
Which keywords describe Maud Maillard's research?
The keywords of their largest research topics: Prognostic Factors, Acute Lymphoblastic Leukemia, Childhood Cancer, Chemotherapy, Mitochondrial Dysfunction, Oxidative Stress, Cetuximab and KRAS Mutations.
- Pharmacogenetics
- Neutropenia
- Genomic Aberrations
- Enzyme Regulation
- Cytochrome P450
- Nephrotoxicity
- KRAS Mutations
- Oxidative Stress
- Chemotherapy
- Acute Lymphoblastic Leukemia
- Prognostic Factors
- Childhood Cancer
- Mitochondrial Dysfunction
- Cetuximab
- Cisplatin
- Chronic Lymphocytic Leukemia
- Drug-Induced Liver Injury
- Genetic Mutations
- Hepatotoxicity
- Nucleotide Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors102 topics
- Acute Lymphoblastic Leukemia81 topic
- Childhood Cancer81 topic
- Chemotherapy72 topics
- Mitochondrial Dysfunction52 topics
- Oxidative Stress52 topics
- Cetuximab41 topic
- KRAS Mutations41 topic
- Cisplatin31 topic
- Nephrotoxicity31 topic
- Chronic Lymphocytic Leukemia21 topic
- Cytochrome P45021 topic
- Drug-Induced Liver Injury21 topic
- Enzyme Regulation21 topic
- Genetic Mutations21 topic
- Genomic Aberrations21 topic
- Hepatotoxicity21 topic
- Neutropenia21 topic
- Nucleotide Metabolism21 topic
- Pharmacogenetics21 topic
Where does Maud Maillard work?
Maud Maillard's main affiliation in the publication record is Institut Claudius Regaud, France.
How many publications and citations does Maud Maillard have?
OpenAlex counts 27 works and 160 citations for Maud Maillard, an h-index of 7, ranking #2,870,022 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Maud Maillard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.